Universal Registration Document

Overview

The report describes Carmat's 2020 CE marking for its artificial heart as a bridge to transplant, enabling future European commercialization. It also reports continued clinical development, with three implants during 2020 and 15 patients treated under the pivotal study by year-end. Carmat recorded no revenue because commercial sales had not yet started, while its workforce increased to 130 employees.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2020
Period: Ends 31 December 2020
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services